Anita Kohli, MD

Arizona Liver Health

Disclosure(s): GlaxoSmithKline: Third party funding to Vir; Vir Biotechnology Inc: Support as a trial site paid to my institution and non-financial support for medical writing support

Poster(s):

• 1150 - Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET